Literature DB >> 26664315

Microaxial Flow Left Ventricular Assist Device as a Bridge to Transplantation after LVAD Malfunction.

Heidi J Reich, Aamir Shah, Babak Azarbal, Jon Kobashigawa, Jaime Moriguchi, Lawrence Czer, Fardad Esmailian.   

Abstract

Evolving technology and improvements in the design of modern, continuous-flow left ventricular assist devices have substantially reduced the rate of device malfunction. As the number of implanted devices increases and as survival prospects for patients with a device continue to improve, device malfunction is an increasingly common clinical challenge. Here, we present our initial experience with an endovascular microaxial flow left ventricular assist device as a successful bridge to transplantation in a 54-year-old man who experienced left ventricular assist device malfunction.

Entities:  

Keywords:  Heart-assist devices; heart transplantation; ventricle-assist devices

Mesh:

Year:  2015        PMID: 26664315      PMCID: PMC4665289          DOI: 10.14503/THIJ-14-4654

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  8 in total

1.  The RECOVER I: a multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support.

Authors:  Bartley P Griffith; Mark B Anderson; Louis E Samuels; Walter E Pae; Yoshifumi Naka; O Howard Frazier
Journal:  J Thorac Cardiovasc Surg       Date:  2012-03-09       Impact factor: 5.209

2.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

3.  Heart transplantation with and without prior sternotomy: analysis of the United Network for Organ Sharing database.

Authors:  P Kansara; L Czer; M Awad; F Arabia; J Mirocha; M De Robertis; J Moriguchi; D Ramzy; R M Kass; F Esmailian; A Trento; J Kobashigawa
Journal:  Transplant Proc       Date:  2014 Jan-Feb       Impact factor: 1.066

4.  Insertion of Impella 5.0 to improve candidacy for HeartMate II left ventricular assist device placement.

Authors:  Navin Rajagopalan; Roh Yanagida; Charles W Hoopes
Journal:  J Invasive Cardiol       Date:  2014-04       Impact factor: 2.022

5.  Use of Impella 5L for acute allograft rejection postcardiac transplant.

Authors:  Rahul Chandola; Robert Cusimano; Mark Osten; Eric Horlick
Journal:  Thorac Cardiovasc Surg       Date:  2012-04-30       Impact factor: 1.827

6.  The Impella device for acute mechanical circulatory support in patients in cardiogenic shock.

Authors:  Anthony Lemaire; Mark B Anderson; Leonard Y Lee; Peter Scholz; Thomas Prendergast; Andrew Goodman; Ann Marie Lozano; Alan Spotnitz; George Batsides
Journal:  Ann Thorac Surg       Date:  2013-10-01       Impact factor: 4.330

7.  Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

8.  Using the Impella 5.0 with a right axillary artery approach as bridge to long-term mechanical circulatory assistance.

Authors:  Matteo Pozzi; Astrid Quessard; Anthony Nguyen; Ciro Mastroianni; Michaela Niculescu; Alain Pavie; Pascal Leprince
Journal:  Int J Artif Organs       Date:  2013-08-02       Impact factor: 1.595

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.